Targeting the untargetable KRAS in cancer therapyPingyu Liu, Xin Li|Acta Pharmaceutica Sinica B|2019Cited by 352
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Shengxiang Ren, Libo Luo et al.|Cancer Cell|2024Cited by 78